This site is intended for healthcare professionals only
LoginRegister
Lupin rolls out constipation drug Prucalopride in US after USFDA nodAlembic Pharma secures USFDA nod for Seizure treatment drug Lamotrigine ER
NPPA Panel Rejects Dr Reddys Omez ODT Plea For Seperate Price, Finds No Therapeutic EdgeDr Reddy's Labs arm Chirotech Technology dissolves
Novartis to buy Tourmaline Bio for USD 1.4 billionCCI approves acquisition of Bharat Serums and Vaccines by Mankind Pharma
AstraZeneca announces Rs 176 crore investments in India to expand Chennai GITCUSFDA grants priority review to AstraZeneca-Daiichi Sankyo Enhertu for HER2-low, HER2 Ultralow...
Jubilant Pharmova to sell API business to wholly owned armZydus Lifesciences bags tentative USFDA nod for Enzalutamide Tablets for prostate cancer
Alembic Pharma wins USFDA approval for pulmonary arterial hypertension drug MacitentanUSFDA nod to Aurobindo Pharma for Cephalexin Tablets
Indian Pharma Market Expands 8.4% in January, Dapagliflozin, Vonoprazan Among Top-Selling Drugs: IQVIACDSCO Panel Approves IQVIA RDS Protocol Amendment Proposal for Survodutide study
Intas Pharma Gets Expert Panel Nod For PMS Data On Tofacitinib Ointment In Atopic DermatitisIntas Pharmaceuticals Gets CDSCO Panel Nod to Study Recombinant Human Follicle Stimulating Hormone
Piramal Pharma Solutions, NewAmsterdam Pharma open dedicated oral solid dosage form suitePiramal Pharma Solutions plans to expand Lexington facility with USD 80 million investment
DPIIT collaborate with Pfizer to strengthen India healthcare innovation ecosystemLupin, Scope Ophthalmics Ireland ink pact to market Optase range of products in Mexico
GSK Blujepa bags USFDA nod for treatment of uUTIs in female adults, paediatric patients 12 years of age and olderCDSCO Panel grants GSK's Protocol Amendment Proposal To Study Belantamab mafodotin
USFDA concludes inspection at Zydus Lifesciences SEZ II, Ahmedabad plantUSFDA issues EIR for Zydus Lifesciences Pharmez transdermal patch manufacturing facility
X